載入...
Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension
INTRODUCTION: The PRONTO-T1D study, which evaluated the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes (T1D), met the primary endpoint of noninferiority of HbA1c change from baseline compared to lispro at 26 weeks. We present results of an additional 26...
Na minha lista:
| 發表在: | Diabetes Ther |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7846637/ https://ncbi.nlm.nih.gov/pubmed/33458803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00987-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|